Patents Assigned to CYRENAIC PHARMACEUTICALS, INC.
  • METHODS OF USE OF CYCLIC AMIDE DERIVATIVES TO TREAT SIGMA RECEPTOR MEDIATED DISORDERS
    Publication number: 20130274290
    Abstract: Disclosed herein are compositions and methods for treating a sigma-2 receptor- mediated condition or disorder, including treating one or more symptoms of a sigma-2 receptor-mediated condition or disorder.
    Type: Application
    Filed: July 20, 2011
    Publication date: October 17, 2013
    Applicant: CYRENAIC PHARMACEUTICALS, INC.
    Inventors: Remy Henri Luthringer, Lorenzo Pellegrini, Argeris N. Karabelas